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MaOBJECTIVES This study sought to investigate the clinical utility and the predictive relevance of absolute rest
myocardial blood ﬂow (MBF) by cardiac magnetic resonance (CMR) in acute myocardial infarction.
BACKGROUND Microvascular obstruction (MVO) remains one of the worst prognostic factors in patients with reper-
fused ST-segment elevation myocardial infarction (STEMI). Clinical trials have focused on cardioprotective strategies to
maintain microvascular functionality, but there is a need for a noninvasive test to determine their efﬁcacy.
METHODS A total of 64 STEMI patients post–primary percutaneous coronary intervention underwent 3-T CMR scans
acutely and at 6 months (6M). The protocol included cine function, T2-weighted edema imaging, pre-contrast T1
mapping, rest ﬁrst-pass perfusion, and late gadolinium enhancement imaging. Segmental MBF, corrected for rate
pressure product (MBFcor), was quantiﬁed in remote, edematous, and infarcted myocardium.
RESULTS Acute MBFcor was signiﬁcantly reduced in infarcted myocardium compared with remote MBF (MBFinfarct 0.76
 0.20 ml/min/g vs. MBFremote 1.02  0.21 ml/min/g, p < 0.001), but it signiﬁcantly increased at 6M (MBFinfarct 0.76 
0.20 ml/min/g acute vs. 0.85  0.22 ml/min/g at 6M, p < 0.001). On a segmental basis, acute MBFcor had incremental
prognostic value for infarct size at 6M (odds of no LGE at 6M increased by 1.4:1 [p < 0.001] for each 0.1 ml/min/g in-
crease of acute MBFcor) and functional recovery (odds of wall thickening >45% at 6M increased by 1.38:1 [p < 0.001] for
each 0.1 ml/min/g increase of acute MBFcor). In subjects with coronary ﬂow reserve >2 or index of myocardial
resistance <40, acute MBF was associated with long-term functional recovery and was an independent predictor of
infarct size reduction.
CONCLUSIONS Acute MBF by CMR could represent a novel quantitative imaging biomarker of microvascular revers-
ibility, and it could be used to identify patients who may beneﬁt from more intensive or novel therapies. (J Am Coll
Cardiol Img 2019;-:-–-) © 2019 The Authors. Published by Elsevier on behalf of the American College of Cardiology
Foundation. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).N 1936-878X https://doi.org/10.1016/j.jcmg.2018.10.028
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ABBR EV I A T I ON S
AND ACRONYMS
6M = 6 month(s)
CFR = coronary ﬂow reserve
CMR = cardiac magnetic
resonance
EF = ejection fraction
FPP = ﬁrst-pass perfusion
IMH = intramyocardial
hemorrhage
IMR = index of microvascular
resistance
IS = infarct size
LGE = late gadolinium
enhancement
LV = left ventricular
MBF = myocardial blood ﬂow
MBFcor = myocardial blood
ﬂow corrected
MBFCULPRIT = average
myocardial blood ﬂow in the
culprit territory
MI = myocardial infarction
MVO = microvascular
obstruction
PPCI = primary percutaneous
coronary intervention
STEMI = ST-segment elevation
myocardial infarction
Tmn = transit time at rest
T2W = T2-weighted
WT = wall thickening
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2D espite the improvement in mortal-ity rates following the introductionof primary percutaneous coronary
intervention (PPCI), the incidence of heart
failure post–myocardial infarction (MI) re-
mains persistently high. Microvascular
impairment despite successful restoration of
epicardial coronary artery patency is associ-
ated with poor long-term recovery and
outcome (1,2). There is a recognized lack of
innovative medical therapy targeting the
microcirculatory function, partly because of
an insufﬁcient understanding of the under-
pinning pathophysiological mechanisms (3).
Invasive coronary measurements such as
the index of microvascular resistance (IMR)
have emerging clinical utility for patients’
stratiﬁcation at the time of PPCI, with
abnormal values being more likely associated
with microvascular obstruction (MVO) (4).
Although standard cardiac magnetic reso-
nance (CMR) techniques such as late gado-
linium enhancement (LGE) allow anatomic
volumetric quantiﬁcation of MVO and intra-
myocardial hemorrhage (IMH) as biomarkers
of severe microvascular disease (5), they do
not provide any insight into microvascular
function. Currently there is no noninvasive
imaging method to stratify patients at risk of
developing MVO or to determine the dy-
namic changes in microvascular impairment
at the time of PPCI.First-pass perfusion (FPP) by CMR for assessment
of myocardial blood ﬂow (MBF) (6) has been
extensively used to estimate abnormal perfusion
in patients with chronic artery disease (7), but a
systematic investigation of MBF in acute STEMI is
lacking.
By using MBF CMR, we sought to investigate: 1) the
degree of microvascular impairment and its longitu-
dinal changes in relation to the severity of ischemic
injury; and 2) the extent to which the acute micro-
vascular dysfunction predicts 6-month (6M) infarct
size (IS) and myocardial functional recovery. This
may help establish CMR as a clinically useful tool to
determine the crucial role played by the microvas-
cular function in the MI healing process and poten-
tially provide novel and speciﬁc imaging biomarkers to
assess the clinical efﬁcacy of cardioprotective strategies.
METHODS
PATIENT STUDY GROUP. Survivors of acutely reper-
fused STEMI post-PPCI were prospectively recruitedbetween October 2010 and March 2015. The study
protocol was approved by the local ethics committee,
and all patients gave written informed consent. Acute
clinical management reﬂected contemporary practice
and guidelines (Supplemental Appendix).
CORONARY PHYSIOLOGY. Transit time at rest (Tmn)
and after hyperemia, coronary ﬂow reserve (CFR),
and IMR measurements were performed at the time of
primary percutaneous coronary intervention (PPCI) in
the infarct-related artery, as previously described (8)
(Supplemental Appendix).
CMR PROTOCOL. CMR was performed on a 3-T
magnetic resonance scanner (either MAGNETOM
TIMTrio or MAGNETOM Verio, Siemens Healthcare,
Erlangen, Germany), acutely (1 to 3 days post-PPCI)
and at 6M. The CMR protocol (details of the se-
quences can be found in the Online Appendix)
included functional cine imaging, tissue character-
ization techniques such edema T2-prepared steady-
state free precession (SSFP) imaging (T2-weighted
[T2W]), native shortened modiﬁed Look-Locker
inversion recovery (ShMOLLI) T1 mapping, FPP at
rest, and LGE. To track the ﬁrst pass of a gadolinium-
based contrast agent, 0.03 mmol/kg gadoterate
meglumine (Dotarem, Guerbet, Villepinte, France)
was injected at rest. LGE images were collected 10 to
15 min after the administration of an additional 0.1
mmol/kg of contrast agent. The inversion time was
adjusted for nulling of remote normal myocardium.
Matching short-axis images covering the entire left
ventricle were acquired using all techniques except
for FPP, which was limited to 3 to 5 matching short-
axis slices.
CMR IMAGING ANALYSIS. CMR analysis is described
in detail in the Supplemental Appendix.
Both global and segmental analyses were per-
formed on anonymized images using cvi42 software
(Circle Cardiovascular Imaging Inc., Calgary, Canada)
by 3 experienced operators (A.B., D.V., A.B.); all of the
images were reviewed by an experienced CMR
cardiologist (E.D.A). Apical slices affected by partial
volume effects and slices where the outﬂow tract was
visible were excluded from the study in all sequences.
For segmental analyses, short-axis images were
divided into 6 equiangular segments with the right
ventricle–left ventricle junction as the reference
point. The wall thickening (WT) analyses at follow-up
were performed by an operator (A.B.) without
knowledge of the baseline analyses. Functional re-
covery at 6M was assessed using a WT cutoff of 45%
(9). Quantiﬁcation of T2W edema and IS on LGE, both
acutely and at 6M, was performed using a signal in-
tensity threshold of 2 SD and 5 SD above the mean
FIGURE 1 Perfusion Quantiﬁcation for Assessment of Resting Segmental MBF
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(A to F) Case #1, anterior infarct with microvascular obstruction (MVO); (G to L) Case #2, inferior infarct with no microvascular obstruction. T1 maps and late gadolinium
enhancement (LGE) images show the infarcted regions (A and B, anterior with microvascular obstruction; G and H, inferior) with hypoperfusion in the corresponding
myocardium on ﬁrst-pass perfusion (FPP) images (C and I). From segmental quantiﬁcation (D and J), the myocardial tissue curves for myocardial blood ﬂow (MBF)
(F and L) demonstrated a reduced myocardial blood ﬂow in the infarcted region (red arrow, red curve) compared with the remote myocardium (blue arrow, blue
curve). (E and K) The arterial input function calculated in the blood pool. a.u. ¼ arbitrary units; LV ¼ left ventricular.
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3intensity of the remote reference region of interest
(ROI), respectively, as previously described (10).
When present, MVO and/or IHM were included in the
measurements of left ventricular (LV) infarct or
edema volume. Segmental tissue state was deﬁned as
remote if negative to LGE and on T2W, edematous if
positive on T2W and negative to LGE, infarcted if
positive to both (with a distinction between LGE 1% to
50% and LGE 51% to 100%), MVO (including segments
with LGE >75% and MVO), and MVO in combination
with IMH (including segments with LGE >75% with
MVO and IMH) on the basis of acute LGE images. IS
reduction was calculated as follows: (acute IS  6M
IS) / acute IS. Native T1 values were derived from
short-axis T1 maps using in-house dedicated software
MC-ROI (Interactive Data Language, version 6.1,
Exelis Visual Information Solutions, Boulder,
Colorado). Quantitative perfusion analysis to deriveabsolute MBF) (ml/min/g) was performed using an
in-house MatLab software, as previously described
(6,7) (Figures 1A to 1L). MBF values were corrected for
the heart rate–blood pressure product by dividing
resting MBF by heart rate (in beats/min)  systolic
blood pressure (mm Hg) / 10,000 (MBF corrected
[MBFcor]). A per subject index of MBF (average MBF in
the culprit territory [MBFCULPRIT]) was calculated
averaging segmental MBFcor of the culprit coronary
artery territory.
STATISTICAL ANALYSIS. Statistical analyses were
performed using IBM SPSS Statistics software (version
22.0, IBM Corporation, Armonk, New York) and the R
statistical environment (version 3.4.1, R Project,
Vienna, Austria). Normally distributed continuous
variables are expressed as mean  SD, and not nor-
mally distributed variables are expressed as median
TABLE 1 Baseline Patient Characteristics (N ¼ 64)
Age, yrs 60  9
Sex, male:female 50:14
Risk factors
Current smoker 18 (30)
Diabetes 4 (7)
Dyslipidemia 17 (28)
Hypertension 22 (36)
Family history of CHD 25 (41)
Peak troponin I (mg/ml) 65 (41–158)
Pain to balloon time (min) 179 (137–239)
Time from PPCI to CMR (days) 2 (1–3)
Culprit coronary artery
LAD 29 (45)
RCA 29 (45)
LCx 6 (10)
No. of vessels diseased
1 41 (67)
2 15 (25)
3 5 (8)
TIMI ﬂow pre-PPCI
0 50 (78)
1 6 (9)
2 7 (11)
3 1 (2)
TIMI ﬂow post-PPCI
0 0 (0)
1 0 (0)
2 4 (6)
3 60 (94)
Medications during PPCI
GP IIb/IIIa inhibitor 8 (13)
Bivalirudin 42 (66)
Heparin 39 (61)
Clopidogrel 10 (16)
Medications post-PPCI
Beta-blockers 61 (95)
ACE inhibitors 62 (97)
Statins 64 (100)
Aspirin 61 (95)
Diuretic 4 (8)
Nitrates 53 (83)
Clopidogrel 53 (83)
Ticagrelor 11 (22)
Invasive measurements post-PPCI (n ¼ 53)
IMR 32 (20–46)
CFR 1.7 (1.3–2.3)
Tmn (ms) 0.8 (0.4–1.2)
Values are mean  SD, n (%), or median (ﬁrst to third quartile).
ACE ¼ angiotensin-converting enzyme; CFR ¼ coronary ﬂow reserve; CHD ¼
coronary heart disease; CMR ¼ cardiac magnetic resonance; GP ¼ glycoprotein;
IMR ¼ index of microvascular resistance; LAD ¼ left anterior descending coronary
artery; LCx ¼ left circumﬂex coronary artery; PPCI ¼ primary percutaneous coro-
nary intervention; RCA ¼ right coronary artery; TIMI ¼ Thrombolysis In Myocardial
Infarction; Tmn ¼ transit time at rest.
TABLE 2 CMR Findings
Acute
(N ¼ 64)
6 Months
(N ¼ 64)
p
Value
EF (%) 47  9 54  9 <0.001
EDV (ml) 153  41 164  42 0.001
ESV (ml) 83  31 76  31 0.002
LGE, 5 SD (LV%)* 25 (14–32) 12 (8–19) <0.001
Edema, 2 SD (LV%)* 40 (33–48) 0 (0–0) <0.001
MSI (%)* 41 (31–60) 68 (58–78) <0.001
MVO patients, n (%) 40 (63) — —
MVO (g)* 0.8 (0–2.6) — —
IMH patients, n (%) 31 (48) — —
IMH (g)* 0 (0–2.9) — —
MBFCULPRIT (ml/min/g) 0.78  0.14 0.87  0.16 <0.001
Heart rate (beats/min) 67  12 57  8 <0.001
Systolic blood pressure
(mm Hg)
113  15 119  18 0.002
Rate pressure product
(beats/min$mm Hg/1e4)
0.75  0.15 0.68  0.15 <0.001
Segmental analysis
WT (%)
WTremote (n ¼ 276) 85  34 88  33 0.200
WTedema (n ¼ 228) 68  29 80  30 <0.001
WTinfarct (n ¼ 406) 36  27 48  28 <0.001
WTMVO (n ¼ 36) 20  17 32  15 0.005
WT MVOþIMH (n ¼ 56) 15  13 18  14 0.062
T1 (ms)
T1remote (n ¼ 150) 1,190  55 1,183  46 0.133
T1edema (n ¼ 152) 1,258  64 1,197  35 <0.001
T1infarct (n ¼ 306) 1,351  86 1,239  56 <0.001
T1MVO (n ¼ 31) 1,340  70 1,281  56 <0.001
T1MVOþIMH (n ¼ 47) 1,386  82 1,280  54 <0.001
MBFcor (ml/min/g)
MBFremote (n ¼ 276) 1.02  0.21 1.08  0.23 <0.001
MBFedema (n ¼ 228) 0.97  0.18 1.03  0.21 <0.001
MBFinfarct (n ¼ 406) 0.76  0.20 0.85  0.22 <0.001
MBFMVO (n ¼ 36) 0.69  0.16 0.76  0.16 <0.001
MBFMVOþIMH (n ¼ 56) 0.59  0.11 0.62  0.10 0.080
Values are mean  SD. *Values were not normally distributed, and the p values
then pertain to a paired Wilcoxon test.
CMR ¼ cardiac magnetic resonance; EDV ¼ end-diastolic volume; EF ¼ ejection
fraction; ESV ¼ end-systolic volume; IMH ¼ intramyocardial hemorrhage; LGE ¼
late gadolinium enhancement; LV ¼ left ventricle; MBFcor, myocardial blood ﬂow
corrected; MBFCULPRIT ¼ average myocardial blood ﬂow in the culprit territory;
MSI ¼ myocardial salvage index; MVO ¼ microvascular obstruction; WT ¼ wall
thickening; 1e4 ¼ 104.
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4and interquartile ranges (ﬁrst quartile to third quar-
tile). The normality of the data was assessed visually
using quantile-quantile plots and by the Shapiro-Wilk
test. For normally distributed variables, comparisonamong groups were performed with unpaired
Student’s t-tests, and comparisons within each group
of follow-up versus baseline used paired Student’s
t-tests. For variables such as %LGE (% of LV mass)
that are not normally distributed, we used Wilcoxon
rank sum and signed rank tests.
The lme4 package (11) for the R statistical envi-
ronment was used to build linear models with mixed
effects (LME) for the analysis of segmental MBFcor
acutely and over 6M follow-up (details in the
Supplemental Appendix).
FIGURE 2 MBFcor Changes Over 6M in Acutely Infarcted Myocardium
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Myocardial blood ﬂow corrected (MBFcor) improves signiﬁcantly at 6 months (6M) in all
segments, with the exception of segments with an acute presentation with microvascular
obstruction (MVO) and intramyocardial hemorrhage (IMH). Bars are SEM. Mean values in
the bars are reported with SD. Asterisk ¼ p < 0.001. LGE ¼ late gadolinium
enhancement.
TABLE 3 Estimated Effect in Mixed-Effects Model for Mean Resting MBFcor,
Acutely and at 6M
Multivariable Associations Coefﬁcient  SE p Value
Linear mixed-effect model for MBF with
tissue state as predictors
(Intercept) 1.00  0.017 <0.001
Edema, acute 0.03  0.016 0.053
LGE 0.18  0.015 <0.001
LGE þ MVO acute 0.38  0.020 <0.001
6M 0.04  0.013 <0.001
Edema 6M 0.00  0.075 0.989
LGE with edema 6M 0.11  0.037 0.002
LGE 6M 0.19  0.013 <0.001
Linear mixed-effect model for MBFcor with
T1 as predictor
(Intercept) 0.90  0.02 <0.001
T1 (100-ms change) 0.09  0.007 <0.001
6M 0.01  0.01 0.409
T1: 6M 0.05  0.016 0.001
A 100-ms change of T1 rather than a 1-s change, was used here to estimate the effect size because
it is of the same order of magnitude as the T1 differences at the acute stage between remote
myocardium and regions with ischemic injury.
6M ¼ 6 months; other abbreviations as in Table 2.
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5To investigate the predictive value of acute rest
MBFcor for LGE, WT at 6M, and WT<45% at 6M, we
used Generalized Additive Models for Location Scale
and Shape (GAMLSS) using acute rest MBFcor, LGE
and MVO as predictors (details in the Supplemental
Appendix). Spearman correlation coefﬁcients were
used to assess any relationships among segmental
MBFcor, WT, and LGE and MBFCULPRIT with invasive
measurements and 6M myocardial functionality.
Receiver-operating characteristic (ROC) analysis was
performed to assess the diagnostic performance of
MBFCULPRIT, LGE, and invasive measurements in the
acute setting in predicting LV dysfunction (ejection
fraction [EF] <50%) at 6M in patients with IMR <40 or
CFR >2. Independent predictors of IS reduction from
acute to 6M, in the same subgroup of patients, were
assessed by adopting linear regression models. Vari-
ables with a p value <0.10 at univariable analysis were
then entered into the multivariable models. The p
values #0.05 were considered statistically signiﬁcant.
RESULTS
Of 104 patients with STEMI who consented, 40 were
excluded because of claustrophobia or technical is-
sues (n ¼ 12), bystander cardiomyopathy (n ¼ 6),
poor-quality image (n ¼ 10), and declined follow-up
scan (n ¼ 12). A total of 64 patients underwent acute
and follow-up scan. The measurement of IMR, CFR,
and Tmn was feasible in 53 of 64 patients. Clinical and
demographic baseline characteristics are shown in
Table 1.
CMR FINDINGS. The CMR ﬁndings are reported in
Table 2. Acutely, all patients had positive edema, and
only 1 had negative LGE; of 40 patients (63%) with
MVO, 31 had also IMH. In 10 patients (i.e., 41 seg-
ments), myocardial edema persisted at 6M. Longitu-
dinal native T1 changes relative to the degree of
injury are also reported in Table 2 and Supplemental
Figure 1A.
LONGITUDINAL MBFcor CHANGES FOLLOWING
ACUTE MI. Acute MBFcor decreased with worsening
ischemic injury (p < 0.001) (Table 2, Supplemental
Figure 1B), with the lowest MBFcor values observed in
infarcted segments with MVO and IMH. Over 6M,
MBFcor improved signiﬁcantly in all segment classes,
including the groups of segments with LGE and/or
MVO. In segments with IMH, MBFcor did not change
signiﬁcantly over time (p ¼ 0.08) (Figure 2).
TISSUE STATE AND SEVERITY OF INJURY BY T1
MAPPING AS DETERMINANTS OF 6M MBFcor
CHANGES. To determine the effect of tissue state on
MBFcor changes between the acute phase and 6M, weused a mixed-effects model for MBFcor, with tissue
state and time point (acute, 6M), and their interaction
as independent predictors. At the acute stage, edema,
LGE, and LGE in combination with MVO were
FIGURE 3 Relationship Between MBFcor and Native T1 Over 6M
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The lines show the prediction from a linear mixed effects model for myocardial blood ﬂow corrected (MBFcor), with native T1 and time point
(with interaction term included) as predictors. The model included a random intercept by patient. The dashed lines show the 95th percentile
ranges for the predictions from the linear mixed effects model. If regression coefﬁcients for the effect of native T1 on myocardial blood ﬂow
are estimated for each tissue state, the association between myocardial blood ﬂow and native T1 is signiﬁcant only in the acute phase for late
gadolinium enhancement with edema, and at 6 months (6M) for edema, late gadolinium enhancement (LGE), and late gadolinium
enhancement with edema. MVO ¼ microvascular obstruction.
TABLE 4 Predictive
(GAMLSS Model)
Multivariable Ass
GAMLSS for LGE 6M
(Intercept)
Acute LGE (%)
Acute MBFcor (ml/mi
MVO (%)
GAMLSS for WT 6M
(Intercept)
Acute LGE (%)
Acute MBFcor (ml/mi
MVO (%)
Acute LGE: acute MB
GAMLSS ¼ Generalized Ad
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6associated with a signiﬁcant reduction of MBFcor by
0.03 ml/min/g (p ¼ 0.05), 0.18 ml/min/g (p < 0.001),
and 0.38 ml/min/g (p < 0.001), respectively (Table 3).
These model predictions are in close agreement with
the differences in acute MBFcor among tissue states
that can be inferred from Table 2. At 6M, there was aValue of Acute MBFcor, LGE, and MVO for 6M LGE and WT
ociations Coefﬁcient  SE t Value p Value
1.7  0.209 8.4 <0.001
0.025  0.002 15.4 <0.001
n/g) 0.564  0.228 2.5 0.013
0.017  0.006 2.6 0.009
74.147  1.522 48.71 <0.001
0.377  0.042 9.01 <0.001
n/g) (centered) 60.066  6.314 9.51 <0.001
0.944  0.238 3.97 <0.001
Fcor 0.360  0.151 2.39 0.017
ditive Models for Location Scale and Shape; other abbreviations as in Table 2 and 3.signiﬁcant, albeit small, overall improvement in
MBFcor (0.04 ml/min/g, p < 0.001), independent of
tissue state. 6M LGE with edema had a by 0.11 ml/
min/g worse effect than acutely (p ¼ 0.002).
Next, we investigated the association between
MBFcor and native T1 as quantitative marker of
severity of injury. Acutely, a 100-ms increase in
myocardial T1 was associated with a signiﬁcant
MBFcor reduction of 0.10  0.007 ml/min/g, whereas
at 6M, an increase in native T1 by 100 ms was asso-
ciated with a further MBFcor reduction by 0.05  0.02
ml/min/g (p ¼ 0.001) (Table 3, Figure 3). We found a
negative association between MBFcor and T1 for all
segments independent of the tissue state (Figure 3).
Notably, if regression coefﬁcients for the effect of
native T1 on MBF are estimated for each tissue state,
the association between MBF and native T1 is signif-
icant only in the acute phase for LGE with edema, and
at 6M for edema, LGE, and LGE with edema.
RELATIONSHIP BETWEEN MBFcor AND 6M INFARCT
SIZE. Both acutely and at 6M, MBFcor was strongly
associated with LGE (Supplemental Figure 2A).
Acute MBFcor had a signiﬁcant effect on 6M LGE,
FIGURE 4 Predictive Value of MBFcor for Final IS and 6M Functional Recovery
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(A) The lines show the predictions for acute myocardial blood ﬂow corrected (MBFcor) equal to 0.3, 0.8, and 1.3 ml/min/g. (B) The observed proportions of segments
with no 6-month (6M) late gadolinium enhancement (LGE) are shown by quartile of acute myocardial blood ﬂow corrected, with 95% conﬁdence intervals. The lines
show the prediction for no 6-month late gadolinium enhancement as a function of acute myocardial blood ﬂow corrected and acute late gadolinium enhancement of
0%, 10%, and 20%. (C) The continuous lines show prediction for acute myocardial blood ﬂow corrected equal to 0.35, 0.70, and 1.40 ml/min/g. (D) The observed
proportions of segments with wall thickening (WT) <45% are shown by quartile of acute myocardial blood ﬂow corrected, with 95% conﬁdence intervals. The lines
show the predictions for wall thickening <45% as a function of acute myocardial blood ﬂow corrected, and 0% and 50% late gadolinium enhancement, and with and
without microvascular obstruction in the case of 50% acute late gadolinium enhancement. IS ¼ infarct size.
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7independent of acute LGE and MVO (p ¼ 0.013)
(Table 4, Figures 4A and 4B). As an example of point
estimates from the model summarized in Table 4, we
note that for segments with LGE of 50% and acute
MBFcor of 0.3 ml/min/g, the predicted IS at 6M (34%)
was w6% larger than in segments with the same LGE
and an acute MBFcor of 0.8 ml/min/g (28% LGE at 6M)
andw11% larger than in segments with same LGE and
an acute MBFcor of 1.3 ml/min/g (23% LGE at 6M)(Figure 4A). There was no evidence of an interaction
between acute LGE and MBFcor for predicting 6M
LGE.
In segments without LGE at 6M, 97% had no acute
LGE, whereas the remaining 3% had a median acute
LGE of 10.5%, which was resorbed over 6M.
Conversely, 9% of segments without acute LGE
showed a median LGE of 13% at 6M. The probability of
no LGE at 6M varied signiﬁcantly with acute MBFcor
TABLE 5 Odds Ratios and 95% Conﬁdence Intervals for Univariate and Multivariate Logistic Regression Model for WT at 6M
>45% (GAMLSS), With Forest Plots for Univariate (A) and Multivariate (B) Regression Analysis
OR 2.5% Percentile for OR 97.5% Percentile for OR t Value p Value
Univariate model
0.1 ml/min/g MBFcor change 1.793 1.62 1.98 11.46 <0.001
100-ms acute T1 change 0.282 0.22 0.36 10.55 <0.001
10% LGE change 0.654 0.61 0.70 13.08 <0.001
10% MVO change 0.026 0.01 0.06 8.10 <0.001
Multivariate model
(Intercept) 0.172 0.12 0.26 8.52 <0.001
0.1 ml/min/g MBFcor change 0.717 0.63 0.82 4.86 <0.001
100 ms acute T1 change 1.667 1.22 2.29 3.17 0.002
10% LGE change 1.098 1.00 1.22 1.79 0.074
10% MVO change 4.437 1.92 10.27 3.48 <0.001
0.02
0.1 ml/min/g MBF change
10% LGE transmurality change
10% MVO change
100 ms acute T1 change
0.1
A
1
OR
2 5
0.1
Intercept
10% LGE transmurality change
10% MVO change
0.1 ml/min/g MBF change
100 ms acute T1 change
B
1
OR
2 10
OR ¼ odds ratio; other abbreviations as in Tables 2 to 4.
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8and LGE, as shown in Figure 4B. The odds of no LGE at
6M increased by 1.4:1 for each 0.1 ml/min/g increase
of acute MBFcor (95% conﬁdence interval: 1.21 to 1.58;
p < 0.001), independent of acute LGE. Each 10% in-
crease of acute LGE decreased the odds of no LGE at
6M by 1:4.7 (p < 0.001).
PREDICTIVE VALUE OF ACUTE MBFcor FOR 6M
SEGMENTAL FUNCTIONAL RECOVERY. Acute MBFcor
and LGE are simultaneous, independent predictors of
6M WT (Table 4, Supplemental Figure 2B and 2C).
Notably, our results show that in segments with
intermediate LGE (Figure 4C), acute MBFcor can
account for the relatively large variability of 6M WT
independent of the level of acute LGE; segments with
intermediate LGE (i.e., 50%) and MBFcor of 0.35 ml/
min/g have a 15% reduction of WT 6M compared with
segments with the same LGE and MBFcor of 0.7 ml/min/g, and a 28% reduction compared with segments
with same LGE and normal MBFcor of 1.0 ml/min/g.
Acute MBFcor impairment decreases the likelihood
of 6M functional recovery (Figure 4D), both in a uni-
variate model that includes only MBFcor (p < 0.001)
and in a multivariate model that also includes acute
T1 (p ¼ 0.001), acute LGE (p ¼ 0.02), and MVO (p ¼
0.001) as additional predictors. In the multivariate
model the odds of WT >45% at 6M increased by 1.38:1
(95% conﬁdence interval: 1.29 to 1.48) for each 0.1 ml/
min/g increase of acute MBFcor (Table 5).
ADDITIONAL PREDICTIVE VALUE OF MBF IN ADDI-
TION TO INVASIVE MEASUREMENTS FOR 6M EF AND
IS REDUCTION. Results for CFR, IMR, and Tmn post-
PPCI are summarized in Table 1.
MBFCULPRIT correlated positively with 6M EF
(R ¼ 0.506, p < 0.001) (Figure 5A). When EF was
FIGURE 5 Relationship Between Acute MBFCULPRIT and EF 6M
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(A) Per patient analysis. (B) Receiver-operating characteristic curves showing the diag-
nostic performance of acute average myocardial blood ﬂow in the culprit territory
(MBFCULPRIT) and late gadolinium enhancement (LGE), index of microvascular resistance
(IMR), coronary ﬂow reserve (CFR), and transit time at rest (Tmn) in predicting left
ventricular (LV) dysfunction (ejection fraction [EF] <50%) at 6 months (6M) in patients
with index of microvascular resistance <40 or coronary ﬂow reserve >2 at the time of
primary percutaneous coronary intervention. AUC ¼ area under the curve.
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9simultaneously adjusted by acute LGE (p ¼ 0.005)
and acute EF (p < 0.001), the association remained
signiﬁcant (p ¼ 0.02). In patients with IMR <40 or
CFR >2 (N ¼ 40), acute MBFCULPRIT and LGE were
equally strong predictors of EF <50% at 6M (area
under the curve: 0.843, p ¼ 0.001 for MBFCULPRIT; and
area under the curve: 0.838, p ¼ 0.002 for LGE)
(Figure 5B). MBFCULPRIT (p ¼ 0.031) was indepen-
dently associated with IS reduction (Table 6).
DISCUSSION
The microcirculation plays a crucial role in infarct
healing as the main supply conduit of oxygen and
nutrients and as a delivery path for pharmacological
treatments. An impairment in microvascular function
is associated with a poor prognosis (12). To the best of
our knowledge, this is the ﬁrst CMR study using ab-
solute MBF quantiﬁcation to systematically estimate
the longitudinal changes in microvascular function
and predict functional recovery following STEMI.
The main ﬁndings of the study are as follows: 1) the
acute microvascular dysfunction is strongly associ-
ated with the extent of the ischemic injury; 2) it is
reversible, depending on the severity of the acute
injury; 3) acute MBFcor, LGE, and MVO are simulta-
neous predictors of ﬁnal IS; 4) MBFcor has incremental
predictive value for ﬁnal IS and segmental recovery,
compared with predictions that are based solely on
acute LGE; and 5) in a lower-risk subgroup of patients
(IMR <40 or CFR >2), acute rest MBF in the culprit
territory may be superior to acute invasive measure-
ments in predicting long-term recovery and may be
an independent predictor of IS reduction. Taken
together, these results suggest that quantifying
myocardial blood at the acute stage leads to an
improved prediction of segmental myocardial
viability and wall motion at follow-up.
The lack of detailed understanding of the patho-
physiological cascade leading up to irreversible
microvascular damage in the context of ischemia-
reperfusion injury has prevented adequate pharma-
cological treatment (3). Previous evidence by positron
emission tomography or CMR stress testing demon-
strated partial recovery of the vasomotor function
over time (13,14); however, such studies were per-
formed in a subacute phase post-MI, and MBF was
assessed in the myocardium pertaining to the culprit
artery, thus leading to values likely not fully repre-
sentative of the severity of injury. For the ﬁrst time,
our ﬁndings clearly show that the progressive dete-
rioration of the acute microvascular function
following ischemic injury is reversible even in
severely damaged tissue. MBF normalization in areaswith intermediate degree of ischemic insult is in line
with pre-clinical evidence showing reversible endo-
thelial damage and increased permeability of the
microvessels at the time of reperfusion (15,16). In
TABLE 6 Multivariable Associations Among Clinical Characteristics, Invasive
Measurements at the Time of PPCI, and Infarct Size Reduction at 6M in Patients With
IMR <40 or CFR >2
IS Reduction From Acute to 6M
Univariable Analysis Multivariable Analysis
Estimate
Coefﬁcient p Value
Estimate
Coefﬁcient p Value
Age (yrs) 0.005 0.163 — —
Male 0.016 0.861 — —
Diabetes 0.144 0.266 — —
Hypertension 0.161 0.026 0.175 0.012
Hypercholesterolemia 0.110 0.165 — —
Active smoking 0.009 0.896 — —
Family history of CHD 0.056 0.413 — —
Pain to balloon time (min) 0.0001 0.152 — —
LAD vs. non-LAD 0.108 0.116 — —
TIMI pre 0.038 0.131 — —
TIMI post 0.114 0.474 — —
CFR PPCI 0.095 0.041 0.201 0.195
IMR PPCI 0.002 0.473 — —
EDV (ml) 0.000 0.710 — —
ESV (ml) 0.000 0.714 — —
EF (%) 0.001 0.733 — —
Acute IS (%) 0.001 0.673 — —
MBFCULPRIT (ml/min/g) 0.350 0.071 0.394 0.031
MVO (yes/no) 0.141 0.037 — —
MVO (%) 0.020 0.206 0.201 0.209
IMH (yes/no) 0.105 0.124 — —
IMH (%) 0.008 0.388 — —
IS ¼ infarct size; other abbreviations as in Table 1 to 3.
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10contrast, for areas with MVO, the underlying mecha-
nisms promoting functional recovery and infarct
reduction are less clear. The infarcted myocardium,
once thought to be “dead,” is actually a dynamic
tissue undergoing an extensive process of remodel-
ing, ultimately forming a core of scar, surrounded by
neoangiogenesis in the infarct border zone (17,18). No
improvement in MBF was seen in infarcted areas with
persistent edema at 6M. As shown recently, residual
iron deposits at 6M following acute IMH resulted
from severe acute microvascular impairment (19).
Therefore, the correlation between persistent edema
and microvascular dysfunction seems plausible and
in line with putative mechanisms for edema in the
presence of capillary leakage or hemorrhage.
In this study, we demonstrate for the ﬁrst time the
incremental role of microvascular function for ﬁnal IS
in segments with intermediate or lower LGE trans-
murality, independent of the extent of the acute LGE
and MVO. The long-term prognostic value of even
small amounts of LGE has been previously studied
(20,21). Our results show that the probability ofhaving no 6M LGE is signiﬁcantly affected by acute
microvascular function, a ﬁnding suggesting that
measures to restore microvascular function after MI
may have longer-term beneﬁts. Unexpectedly, we
found that a small fraction of segments without LGE
acutely were positive to LGE at 6M. There are at least
3 potential explanations for this ﬁnding: 1) a
mismatch of short-axis positions imaged at different
time points; 2) lower diagnostic performance of
standard CMR techniques such as T2W and LGE
compared with more accurate parametric maps to
quantify ischemic injury; and 3) late development of
necrotic tissue within an area at risk.
Finally, our study shows that in patients with pre-
served microvascular function as assessed by invasive
measurements post-PPCI (i.e., IMR <40 or CFR >2),
acute MBF estimates of microvascular function could
provide a tool to stratify patients and predict LV
remodeling. The predictive relevance of the changes
in microvascular function early after PPCI are known
(8): CMR MBF assessment could represent a valid
alternative to invasive repeated measurements.
STUDY LIMITATIONS. The results of this study
should be interpreted in light of some limitations. In
this study, continuous variables such as MBF and
native T1 represent averages for each myocardial
segment. Any estimate of an effect modiﬁcation of
MVO in the relationship of native T1 and MBF is likely
not representative of MVO itself because MVO in most
segments represented a relatively small subarea of a
myocardial segment. Our IMR measurements (median
32; interquartile range: 20 to 46) are comparable to
those in previous studies (4,22); however, we did not
ﬁnd a signiﬁcant relationship between IMR and MVO/
MBFCULPRIT. There may be several reasons for this,
including the small sample size and the assessment of
resting perfusion rather than stress perfusion 3 days
after the invasive coronary measurements (8).
Further larger studies are needed to corroborate our
ﬁndings.
CONCLUSIONS
Microvascular function estimated using CMR MBF
has additional clinical and prognostic value beyond
tissue characterization. In the context of novel po-
tential therapeutic targets such as endothelial
integrity, vascular permeability, or angiogenesis (23),
MBF measurements could represent a useful nonin-
vasive tool for risk stratiﬁcation of patients with
STEMI post-PPCI and to guide cardioprotective
treatment.
PERSPECTIVES
COMPETENCY IN MEDICAL KNOWLEDGE: Acute micro-
vascular impairment is dynamic and reversible over time. Beyond
EF and IS, acute microvascular function has incremental prog-
nostic value for LV remodeling.
TRANSLATIONAL OUTLOOK: Further studies are required to
determine whether adjunct therapy targeting microvascular
function at the time of PPCI will improve patients’ outcomes.
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